{"id":13668,"date":"2025-06-05T10:02:45","date_gmt":"2025-06-05T10:02:45","guid":{"rendered":"https:\/\/www.eurobio-scientific.com\/?post_type=press-releases&#038;p=13668"},"modified":"2025-06-25T15:21:43","modified_gmt":"2025-06-25T15:21:43","slug":"2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business","status":"publish","type":"press-releases","link":"https:\/\/www.eurobio-scientific.com\/fr\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/","title":{"rendered":"R\u00e9sultats annuels 2022 : tr\u00e8s bonnes performances et renforcement des activit\u00e9s de base"},"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"press":[279],"class_list":["post-13668","press-releases","type-press-releases","status-publish","hentry","press-279"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>2022 annual results : very strong performance and strengthening of the Core Business | Eurobio-Scientific<\/title>\n<meta name=\"description\" content=\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation &amp; oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2022 annual results : very strong performance and strengthening of the Core Business\" \/>\n<meta property=\"og:description\" content=\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation &amp; oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Eurobio-Scientific\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-25T15:21:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\\\/\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\\\/\",\"name\":\"2022 annual results : very strong performance and strengthening of the Core Business | Eurobio-Scientific\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#website\"},\"datePublished\":\"2025-06-05T10:02:45+00:00\",\"dateModified\":\"2025-06-25T15:21:43+00:00\",\"description\":\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/press-releases\\\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2022 annual results : very strong performance and strengthening of the Core Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#website\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\",\"name\":\"eurobio-scientific.com\",\"description\":\"Experts in diagnostic solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#organization\"},\"alternateName\":\"eurobio-scientific.fr\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#organization\",\"name\":\"Eurobio Scientific\",\"alternateName\":\"Eurobio Scientific\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png\",\"contentUrl\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png\",\"width\":612,\"height\":204,\"caption\":\"Eurobio Scientific\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/eurobio-scientific\\\/\"],\"description\":\"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions\",\"email\":\"contact@eurobio-scientific.com\",\"telephone\":\"+33 169796480\",\"legalName\":\"Eurobio Scientific\",\"foundingDate\":\"1962-02-14\",\"vatID\":\"TVAFR414488171\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"},\"actionableFeedbackPolicy\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/privacy-policy\\\/\",\"correctionsPolicy\":\"https:\\\/\\\/www.eurobio-scientific.com\\\/privacy-policy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"2022 annual results : very strong performance and strengthening of the Core Business | Eurobio-Scientific","description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions et celles de nos partenaires.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/","og_locale":"fr_FR","og_type":"article","og_title":"2022 annual results : very strong performance and strengthening of the Core Business","og_description":"The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation & oncology by developing and supporting a comprehensive portfolio of molecular diagnostics technologies encompassing our own solutions and those of our partners.","og_url":"https:\/\/www.eurobio-scientific.com\/fr\/communiques-de-presse\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/","og_site_name":"Eurobio-Scientific","article_modified_time":"2025-06-25T15:21:43+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/","url":"https:\/\/www.eurobio-scientific.com\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/","name":"2022 annual results : very strong performance and strengthening of the Core Business | Eurobio-Scientific","isPartOf":{"@id":"https:\/\/www.eurobio-scientific.com\/#website"},"datePublished":"2025-06-05T10:02:45+00:00","dateModified":"2025-06-25T15:21:43+00:00","description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions et celles de nos partenaires.","breadcrumb":{"@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurobio-scientific.com\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurobio-scientific.com\/press-releases\/2022-annual-results-very-strong-performance-and-strengthening-of-the-core-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurobio-scientific.com\/"},{"@type":"ListItem","position":2,"name":"2022 annual results : very strong performance and strengthening of the Core Business"}]},{"@type":"WebSite","@id":"https:\/\/www.eurobio-scientific.com\/#website","url":"https:\/\/www.eurobio-scientific.com\/","name":"eurobio-scientific.com","description":"Eurobio Scientific I Experts en solutions de diagnostic","publisher":{"@id":"https:\/\/www.eurobio-scientific.com\/#organization"},"alternateName":"eurobio-scientific.fr","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurobio-scientific.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.eurobio-scientific.com\/#organization","name":"Eurobio Scientific","alternateName":"Eurobio Scientific","url":"https:\/\/www.eurobio-scientific.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.eurobio-scientific.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurobio-scientific.com\/wp-content\/uploads\/2024\/09\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png","contentUrl":"https:\/\/www.eurobio-scientific.com\/wp-content\/uploads\/2024\/09\/cropped-cropped-Logo-EBS_Plan-de-travail-1.png","width":612,"height":204,"caption":"Eurobio Scientific"},"image":{"@id":"https:\/\/www.eurobio-scientific.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/eurobio-scientific\/"],"description":"Le groupe Eurobio Scientific est \u00e0 la pointe de l'innovation dans les domaines des maladies infectieuses, de la transplantation et de l'oncologie en d\u00e9veloppant et en soutenant un portefeuille complet de technologies de diagnostic mol\u00e9culaire comprenant nos propres solutions.","email":"contact@eurobio-scientific.com","telephone":"+33 169796480","legalName":"Eurobio Scientific","foundingDate":"1962-02-14","vatID":"TVAFR414488171","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"},"actionableFeedbackPolicy":"https:\/\/www.eurobio-scientific.com\/privacy-policy\/","correctionsPolicy":"https:\/\/www.eurobio-scientific.com\/privacy-policy\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases\/13668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases"}],"about":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/types\/press-releases"}],"version-history":[{"count":0,"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press-releases\/13668\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/media?parent=13668"}],"wp:term":[{"taxonomy":"press","embeddable":true,"href":"https:\/\/www.eurobio-scientific.com\/fr\/wp-json\/wp\/v2\/press?post=13668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}